AT354636B - Verfahren zur herstellung eines praeparates mit gesteuerter abgabe einer aktiven komponente - Google Patents
Verfahren zur herstellung eines praeparates mit gesteuerter abgabe einer aktiven komponenteInfo
- Publication number
- AT354636B AT354636B AT850576A AT850576A AT354636B AT 354636 B AT354636 B AT 354636B AT 850576 A AT850576 A AT 850576A AT 850576 A AT850576 A AT 850576A AT 354636 B AT354636 B AT 354636B
- Authority
- AT
- Austria
- Prior art keywords
- producing
- preparation
- active component
- controlled delivery
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7512883A SE418247B (sv) | 1975-11-17 | 1975-11-17 | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
Publications (2)
Publication Number | Publication Date |
---|---|
AT354636B true AT354636B (de) | 1979-01-25 |
ATA850576A ATA850576A (de) | 1979-06-15 |
Family
ID=20326096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT850576A AT354636B (de) | 1975-11-17 | 1976-11-16 | Verfahren zur herstellung eines praeparates mit gesteuerter abgabe einer aktiven komponente |
Country Status (24)
Country | Link |
---|---|
US (2) | US4289795A (de) |
JP (1) | JPS5919526B2 (de) |
AT (1) | AT354636B (de) |
AU (1) | AU508266B2 (de) |
BE (1) | BE848406A (de) |
CA (1) | CA1075031A (de) |
CS (1) | CS207374B2 (de) |
DD (1) | DD128170A5 (de) |
DE (1) | DE2651176A1 (de) |
DK (1) | DK146213C (de) |
FI (1) | FI62462C (de) |
FR (1) | FR2331375A1 (de) |
GB (1) | GB1560841A (de) |
HK (1) | HK14683A (de) |
HU (1) | HU173461B (de) |
IE (1) | IE44353B1 (de) |
LU (1) | LU76215A1 (de) |
MY (1) | MY8400019A (de) |
NL (1) | NL187259C (de) |
NO (1) | NO144763C (de) |
NZ (1) | NZ182621A (de) |
SE (1) | SE418247B (de) |
SU (1) | SU1326180A3 (de) |
ZA (1) | ZA766669B (de) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0094117A2 (de) * | 1982-05-06 | 1983-11-16 | The Procter & Gamble Company | Therapeutische Granulate |
EP0094123A2 (de) * | 1982-05-06 | 1983-11-16 | THE PROCTER & GAMBLE COMPANY | Therapeutische Granulate |
EP0094116A2 (de) * | 1982-05-06 | 1983-11-16 | The Procter & Gamble Company | Therapeutische Granulate |
EP0097523A3 (en) * | 1982-06-21 | 1984-12-12 | Euroceltique Sa | Extended action controlled release compositions |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE426548B (sv) * | 1978-12-05 | 1983-01-31 | Haessle Ab | Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer |
FR2470600A2 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee |
IE48715B1 (en) * | 1978-12-22 | 1985-05-01 | Elan Corp Plc | New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same |
SE7813246L (sv) | 1978-12-22 | 1980-06-23 | Haessle Ab | Fast farmaceutisk beredning innehallande kroppar med flera ytskikt |
FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
JPS5911563B2 (ja) * | 1980-02-27 | 1984-03-16 | 日本原子力研究所 | 多層構造の徐放性複合体を製造する方法 |
ATE14379T1 (de) * | 1981-04-27 | 1985-08-15 | Haessle Ab | Pharmazeutisches praeparat. |
JPS5858146A (ja) * | 1981-10-05 | 1983-04-06 | Tanabe Seiyaku Co Ltd | 速放性マイクロカプセル |
US4370313A (en) * | 1981-10-26 | 1983-01-25 | Eaton Laboratories, Inc. | Nitrofurantoin dosage form |
US4508702A (en) * | 1982-06-14 | 1985-04-02 | Key Pharmaceuticals, Inc. | Sustained release aspirin |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
WO1984000004A1 (en) * | 1982-06-14 | 1984-01-05 | Key Pharma | Sustained release aspirin |
US4634587A (en) * | 1982-07-09 | 1987-01-06 | Key Pharmaceuticals, Inc. | Sustained release quinidine dosage form |
DE3382392D1 (de) * | 1982-07-09 | 1991-10-02 | Key Pharma | Dosierungsart zur dauerhaften verabreichung von chinidin. |
CA1223172A (en) * | 1982-09-23 | 1987-06-23 | Sidney Melamed | Encapsulated solid microbiocidal article |
US5283060A (en) * | 1982-09-29 | 1994-02-01 | Shieh Tsuong R | Bacillus-containing pesticide granules |
IL70071A (en) * | 1982-11-01 | 1987-12-31 | Merrell Dow Pharma | Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient |
US4461759A (en) * | 1983-01-03 | 1984-07-24 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of veropamil |
JPS59155309A (ja) * | 1983-02-22 | 1984-09-04 | Teijin Ltd | 活性型ビタミンd↓3類組成物 |
DE3306250A1 (de) * | 1983-02-23 | 1984-08-23 | Basf Ag, 6700 Ludwigshafen | Sphaerische einkristalle fuer pharmazeutische zwecke |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
GB2141023B (en) * | 1983-06-06 | 1986-09-03 | Robins Co Inc A H | Delayed release formulations |
US4555399A (en) * | 1983-11-18 | 1985-11-26 | Key Pharmaceuticals, Inc. | Aspirin tablet |
US4708867A (en) * | 1983-12-19 | 1987-11-24 | Key Pharmaceuticals, Inc. | Minipellets |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
DE3403329A1 (de) * | 1984-02-01 | 1985-08-01 | Horst Dr. 4019 Monheim Zerbe | Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe |
US4600645A (en) * | 1985-01-31 | 1986-07-15 | Warner-Lambert Company | Process for treating dosage forms |
US4693886A (en) * | 1985-04-22 | 1987-09-15 | Alza Corporation | Osmotic device with inert core |
SE458576B (sv) * | 1985-06-20 | 1989-04-17 | Lejus Medical Ab | Foerfarande foer framstaellning av en guar-gum produkt |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
SE455836B (sv) * | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
US4898733A (en) * | 1985-11-04 | 1990-02-06 | International Minerals & Chemical Corp. | Layered, compression molded device for the sustained release of a beneficial agent |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
US5019302A (en) * | 1986-03-12 | 1991-05-28 | Washington University Technology Associates, Inc. | Method for granulation |
US5100592A (en) * | 1986-03-12 | 1992-03-31 | Washington University Technology Associated, Inc. | Method and apparatus for granulation and granulated product |
US4861598A (en) * | 1986-07-18 | 1989-08-29 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
US5624683A (en) * | 1986-08-06 | 1997-04-29 | Eisai Co., Ltd. | Sustained-release multi-granule tablet |
IT1200217B (it) * | 1986-09-30 | 1989-01-05 | Valducci Roberto | Membrana per uso farmaceutico ed industriale |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
EP0294493A4 (de) * | 1986-12-25 | 1989-07-24 | Teysan Pharmaceuticals Co Ltd | Langsamlösliches granulatkorn und daraus hergestelltes langwirkendes mischgranulat. |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
GB8702411D0 (en) * | 1987-02-03 | 1987-03-11 | Zyma Sa | Swellable pellets |
HU197519B (en) * | 1987-06-22 | 1989-04-28 | Biogal Gyogyszergyar | Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade |
DE3720757A1 (de) * | 1987-06-24 | 1989-01-05 | Bayer Ag | Dhp-manteltablette |
US5219575A (en) * | 1987-06-26 | 1993-06-15 | Duphar International Research B.V. | Compositions with controlled zero-order delivery rate and method of preparing these compositions |
EP0297650A1 (de) * | 1987-06-26 | 1989-01-04 | Duphar International Research B.V | Zusammensetzungen mit Freisetzung nullter Ordnung und Verfahren zu ihrer Herstellung |
DE3721721C1 (de) * | 1987-07-01 | 1988-06-09 | Hoechst Ag | Verfahren zur Umhuellung von Granulaten |
IT1231410B (it) * | 1987-09-22 | 1991-12-04 | Cooperativa Farmaceutica | Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico |
SE8703881D0 (sv) * | 1987-10-08 | 1987-10-08 | Haessle Ab | New pharmaceutical preparation |
US4971805A (en) * | 1987-12-23 | 1990-11-20 | Teysan Pharmaceuticals Co., Ltd. | Slow-releasing granules and long acting mixed granules comprising the same |
US4925675A (en) * | 1988-08-19 | 1990-05-15 | Himedics, Inc. | Erythromycin microencapsulated granules |
US4925674A (en) * | 1988-08-25 | 1990-05-15 | Himedics, Inc. | Amoxicillin microencapsulated granules |
US4971796A (en) * | 1988-10-05 | 1990-11-20 | Sjogren Robert D | Slow release pest control granule composition |
DE3838094A1 (de) * | 1988-11-10 | 1990-05-17 | Nordmark Arzneimittel Gmbh | Feste pharmazeutische retardform |
EP0376331A3 (de) * | 1988-12-29 | 1991-03-13 | Asahi Kogaku Kogyo Kabushiki Kaisha | Granula zur langsamen Wirkstoffabgabe sowie Verfahren zu deren Herstellung |
US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
DE3918801A1 (de) * | 1989-06-06 | 1991-05-08 | Schmidt Walter | Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung |
JP2813809B2 (ja) * | 1989-06-19 | 1998-10-22 | 武田薬品工業株式会社 | 有核顆粒製剤およびその製造法 |
US4966770A (en) * | 1989-07-26 | 1990-10-30 | Himedics, Inc. | Prednisone microencapsulated granules |
US6638963B1 (en) | 1990-12-04 | 2003-10-28 | Oregon Health And Science University | Methods for treating circadian rhythm disorders |
US5707652A (en) * | 1990-12-04 | 1998-01-13 | State Of Oregon | Methods of treating circadian rhythm phase disorders |
US5153002A (en) * | 1991-03-04 | 1992-10-06 | University Of Montreal | Biocompatible gradient controlled release implant |
FI93924C (fi) * | 1991-09-17 | 1995-06-26 | Martti Lauri Antero Marvola | Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi |
GB2267219B (en) * | 1992-05-28 | 1996-04-03 | Elan Corp Plc | Differential release tablet with multiple active agents |
KR100297541B1 (ko) * | 1992-12-13 | 2001-11-26 | 마티에우 디올라이티 | 방출제어형약학적제형의제조방법및이방법에의해제조된약학적제형 |
IT1274879B (it) * | 1994-08-03 | 1997-07-25 | Saitec Srl | Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo. |
DE4446468A1 (de) * | 1994-12-23 | 1996-06-27 | Basf Ag | Verfahren zur Herstellung von umhüllten Tabletten |
US5762963A (en) * | 1995-06-07 | 1998-06-09 | Emory University | Method and compositions for controlling oral and pharyngeal pain using capsaicinoids |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
GB9703673D0 (en) * | 1997-02-21 | 1997-04-09 | Bradford Particle Design Ltd | Method and apparatus for the formation of particles |
EP1949890A3 (de) | 1999-06-04 | 2011-05-18 | ALZA Corporation | Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür |
HUP0201626A3 (en) * | 1999-06-04 | 2004-05-28 | Alza Corp Mountain View | Implantable gel compositions and method of manufacture |
WO2001080826A2 (en) | 2000-04-20 | 2001-11-01 | Bristol-Myers Squibb Company | Taste masking coating composition |
KR100402053B1 (ko) * | 2000-09-28 | 2003-10-17 | 한국화학연구원 | 항생제의 서방성 임플란트 제제 |
GB0027357D0 (en) | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
ES2663873T3 (es) * | 2001-10-29 | 2018-04-17 | Massachusetts Institute Of Technology | Forma farmacéutica con perfil de liberación de orden cero fabricada por impresión tridimensional |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
GB0216562D0 (en) | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
GB0228421D0 (en) * | 2002-12-05 | 2003-01-08 | Exosect Ltd | Lipid carriers |
DE10260919A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug |
AU2004237131B2 (en) | 2003-05-08 | 2009-09-10 | Nektar Therapeutics | Particulate materials |
GB0310636D0 (en) * | 2003-05-08 | 2003-06-11 | Nektar Therapeutics Uk Ltd | Particulate materials |
KR20070036019A (ko) * | 2004-03-31 | 2007-04-02 | 이아이디 패리 (인디아) 리미티드 | 님 종자 추출물의 개선된 과립 제제 및 이것의 제조 공정 |
US20050244465A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Drug delivery systems and methods for treatment of an eye |
US20060147517A1 (en) * | 2005-01-06 | 2006-07-06 | Cima Labs Inc. | Taste masking system for non-plasticizing drugs |
US9808030B2 (en) | 2011-02-11 | 2017-11-07 | Grain Processing Corporation | Salt composition |
CA2902911C (en) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
BE623704A (de) * | 1961-10-20 | |||
US3383283A (en) * | 1964-01-24 | 1968-05-14 | Merck & Co Inc | Medicinal pellets coated with overlapping porous fatty acid leaflet layers |
FR1545612A (fr) * | 1967-06-15 | 1968-11-15 | Dausse Lab | Procédé de fabrication de comprimés |
DE1617351A1 (de) * | 1967-06-28 | 1972-01-05 | ||
DK123806B (da) * | 1970-06-08 | 1972-08-07 | Pharmacia As | Fremgangsmåde til fremstilling af tabletter eller piller med langsom afgivelse af et aktivt stof. |
BE791632A (fr) * | 1971-11-20 | 1973-05-21 | Schering Ag | Supports a base de caoutchouc siliconique pour agents medicamenteux |
BE792502A (fr) * | 1971-12-09 | 1973-06-08 | Upjohn Co | Nouvelles formes pharmaceutiques et leur procede de preparation |
-
1975
- 1975-11-17 SE SE7512883A patent/SE418247B/xx not_active IP Right Cessation
-
1976
- 1976-11-08 ZA ZA766669A patent/ZA766669B/xx unknown
- 1976-11-09 NO NO763807A patent/NO144763C/no unknown
- 1976-11-10 DE DE19762651176 patent/DE2651176A1/de active Granted
- 1976-11-12 FI FI763257A patent/FI62462C/fi not_active IP Right Cessation
- 1976-11-15 NZ NZ182621A patent/NZ182621A/xx unknown
- 1976-11-15 AU AU19617/76A patent/AU508266B2/en not_active Expired
- 1976-11-15 DD DD7600195783A patent/DD128170A5/de unknown
- 1976-11-15 DK DK513476A patent/DK146213C/da not_active IP Right Cessation
- 1976-11-16 CS CS767375A patent/CS207374B2/cs unknown
- 1976-11-16 CA CA265,748A patent/CA1075031A/en not_active Expired
- 1976-11-16 AT AT850576A patent/AT354636B/de not_active IP Right Cessation
- 1976-11-16 IE IE2516/76A patent/IE44353B1/en not_active IP Right Cessation
- 1976-11-16 GB GB47730/76A patent/GB1560841A/en not_active Expired
- 1976-11-16 FR FR7634515A patent/FR2331375A1/fr active Granted
- 1976-11-16 NL NLAANVRAGE7612728,A patent/NL187259C/xx not_active IP Right Cessation
- 1976-11-17 LU LU76215A patent/LU76215A1/xx unknown
- 1976-11-17 JP JP51137414A patent/JPS5919526B2/ja not_active Expired
- 1976-11-17 BE BE172413A patent/BE848406A/xx not_active IP Right Cessation
- 1976-11-17 HU HU76HE724A patent/HU173461B/hu unknown
- 1976-11-17 SU SU762420506A patent/SU1326180A3/ru active
-
1979
- 1979-02-21 US US06/013,124 patent/US4289795A/en not_active Expired - Lifetime
-
1980
- 1980-10-27 US US06/200,998 patent/US4341759A/en not_active Expired - Lifetime
-
1983
- 1983-05-05 HK HK146/83A patent/HK14683A/xx unknown
-
1984
- 1984-12-30 MY MY19/84A patent/MY8400019A/xx unknown
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0094117A2 (de) * | 1982-05-06 | 1983-11-16 | The Procter & Gamble Company | Therapeutische Granulate |
EP0094123A2 (de) * | 1982-05-06 | 1983-11-16 | THE PROCTER & GAMBLE COMPANY | Therapeutische Granulate |
EP0094116A2 (de) * | 1982-05-06 | 1983-11-16 | The Procter & Gamble Company | Therapeutische Granulate |
EP0094123A3 (de) * | 1982-05-06 | 1984-07-25 | THE PROCTER & GAMBLE COMPANY | Therapeutische Granulate |
EP0094117A3 (de) * | 1982-05-06 | 1984-08-01 | The Procter & Gamble Company | Therapeutische Granulate |
EP0094116A3 (de) * | 1982-05-06 | 1984-08-01 | The Procter & Gamble Company | Therapeutische Granulate |
EP0097523A3 (en) * | 1982-06-21 | 1984-12-12 | Euroceltique Sa | Extended action controlled release compositions |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT354636B (de) | Verfahren zur herstellung eines praeparates mit gesteuerter abgabe einer aktiven komponente | |
AT352509B (de) | Verfahren zur herstellung eines aufstrich- mittels mit niedrigem fettgehalt | |
AT362492B (de) | Verfahren zur herstellung eines stabilen insulinpraeparats mit dauerwirkung | |
AT347038B (de) | Verfahren zur herstellung eines diaetpraeparats | |
ATA971776A (de) | Verfahren zur herstellung eines stabilen antibiotischen praparates | |
AT360148B (de) | Verfahren zur herstellung einer stabilen injektionsloesung | |
AT353415B (de) | Verfahren zur herstellung eines pharma- zeutischen praeparates | |
ATA843476A (de) | Verfahren zur herstellung einer stabilen lyopilisierbaren bzw. lyophilisierten erythro- zyten-praeparation | |
AT386744B (de) | Verfahren zur herstellung eines wundheilmittels | |
AT348315B (de) | Verfahren zur herstellung eines aufstrich- mittels mit niedrigem fettgehalt | |
AT355214B (de) | Verfahren zur herstellung einer stabilen emulsion einer sauerstoff-uebertragenden perfluorkohlenstoff-verbindung | |
AT361632B (de) | Verfahren zur herstellung einer waessrigen instillationszubereitung | |
AT361280B (de) | Verfahren zur herstellung eines stabilen nahrungs- und futtermittels | |
DD132232A5 (de) | Verfahren zur herstellung eines oral verabfolgbaren cephalexinpraeparates mit verzoegerter wirkstoffabgabe | |
DD131019A5 (de) | Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides | |
AT370625B (de) | Verfahren zur herstellung einer stabilen waesserigen injektionsloesung eines oxytetracyclin- -erdalkalimetall-chelats | |
AT343276B (de) | Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung | |
ATA541377A (de) | Verfahren zur herstellung einer pharmazeutischen zusammensetzung | |
AT363600B (de) | Verfahren zur herstellung einer waesserigen loesung eines rafoxanide-polyvinylpyrrolidon-komplexes | |
AT351914B (de) | Verfahren zur herstellung eines aufstrich- mittels mit niedrigem fettgehalt | |
ATA209076A (de) | Verfahren zur herstellung einer topischen zubereitung | |
AT353543B (de) | Verfahren zur herstellung eines nagetierbe- kaempfungsmittels | |
AT366056B (de) | Verfahren zur herstellung eines phosphordichloridothiolats | |
AT344676B (de) | Verfahren zur herstellung einer perpropionsaeureloesung | |
DD133672A5 (de) | Verfahren zur herstellung eines saeureadditionssalzes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |